A31.9 Mycobacterial infection, unspecified

Name of the Condition

• Mycobacterial infection, unspecified

Summary

Mycobacterial infection, unspecified is a condition caused by bacteria from the Mycobacterium genus, excluding Mycobacterium tuberculosis and Mycobacterium leprae. These infections, often referred to as nontuberculous mycobacteria (NTM) infections, can affect various body systems and may present with diverse clinical manifestations depending on the site of infection.

Causes

These infections are caused by mycobacteria commonly found in environmental sources such as water, soil, and biofilms. Transmission typically occurs through inhalation of contaminated aerosols, direct contact with infected tissues, or exposure to contaminated water or soil.

Risk Factors

• Weakened immune system: Conditions like HIV/AIDS, immunosuppressive therapies, or chronic diseases can increase susceptibility.
• Pre-existing lung conditions: Chronic obstructive pulmonary disease (COPD), bronchiectasis, or cystic fibrosis may predispose individuals.
• Environmental exposure: Frequent contact with contaminated water sources (e.g., hot tubs, swimming pools) or soil.

Symptoms

• Chronic cough with sputum production (if pulmonary)
• Fatigue and weight loss
• Skin lesions, nodules, or ulcers (if cutaneous)
• Swollen lymph nodes (if lymphatic involvement)
• Fever and night sweats

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., chest X-rays or CT scans), and laboratory testing. Cultures of affected tissues or fluids, along with molecular tests like PCR, help identify the specific mycobacterial species. Biopsies may be performed to assess tissue involvement.

Treatment Options

Treatment typically involves prolonged courses of antibiotics tailored to the specific mycobacterial species and site of infection. Therapy may include a combination of medications, and duration depends on the severity and location of the infection. Surgical intervention may be necessary in some cases, such as for localized abscesses or severe tissue damage.

Prognosis and Follow-Up

Prognosis varies based on the site of infection, the patient’s overall health, and response to treatment. Early diagnosis and appropriate therapy improve outcomes. Follow-up care includes monitoring for treatment response, managing side effects of medications, and assessing for recurrence or complications.

Complications

• Progressive lung damage or respiratory failure (if pulmonary)
• Disseminated infection affecting multiple organs
• Chronic skin ulcers or tissue destruction (if cutaneous)
• Lymph node enlargement or abscess formation

Lifestyle & Prevention

• Avoid exposure to contaminated water sources, especially in high-risk environments like hot tubs or poorly maintained pools.
• Practice good wound care to prevent skin infections, particularly in immunocompromised individuals.
• Maintain overall health to support immune function, including managing chronic conditions and avoiding unnecessary immunosuppression when possible.

When to Seek Professional Help

Seek medical attention if you experience persistent respiratory symptoms (e.g., chronic cough, shortness of breath), unexplained weight loss, skin lesions that do not heal, or swollen lymph nodes. Prompt evaluation is important for early diagnosis and treatment.

Tips for Medical Coders

Use this code for unspecified mycobacterial infections when the specific site or type is not documented. Ensure documentation supports the diagnosis, as specificity may be required for accurate coding. Verify that the infection is not attributable to Mycobacterium tuberculosis or Mycobacterium leprae, which have separate codes.